Volume 13, Issue 7 (9-2015)                   IJRM 2015, 13(7): 439-444 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Soleimani Rad S, Abbasalizadeh S, Ghorbani Haghjo A, Sadagheyani M, Montaseri A, Soleimani Rad J. Evaluation of the melatonin and oxidative stress markers level in serum of fertile and infertile women. IJRM 2015; 13 (7) :439-444
URL: http://ijrm.ir/article-1-661-en.html
1- Department of Obstetrics and Gynecology, Alzahra Hospital, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
2- Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz-Iran
3- Department of Medical Biochemistry, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
4- Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran
5- Department of Anatomical Sciences, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran , soleimanirj@yahoo.com
Abstract:   (2427 Views)
Background: Infertility is defined as the inability to achieve the pregnancy within a year of unprotected intercourse. Infertility is a complex issue and different factors such as stress oxidative can be involved in this problem. So, any attempt to neutralize oxidative stress would be helpful in the treatment of infertility. Melatonin is a known scavenger of free radicals.
Objective: The aim of our study was to evaluate the level of melatonin and its correlation with oxidative biomarkers in fertile and infertile women.
Materials and Methods: The participants including fertile and infertile women were divided into two groups of 30 people. Blood sampling was performed and sera were collected. The level of Malondialdehyde (MDA), total antioxidant capacity (TAC) and melatonin were detected. Data were analyzed using T-test and their correlation was assessed using Spearman test.
Results: Serum melatonin from fertile women was higher than infertile women but the difference was not significant (p= 0.46). MDA level in fertile women was significantly lower than infertile women (p<0.001) and the level of TAC in fertile women was significantly higher than infertile women (p<0.001). Spearman test revealed a significant and direct correlation between melatonin and TAC in fertile and infertile women and a significant but reverse correlation between melatonin and MDA in infertile and fertile women.
Conclusion: Differences in the level of oxidative stress biomarkers in fertile and infertile individuals have been reported. This study revealed a significant correlation between melatonin and oxidative stress biomarkers, concluding that melatonin level could be involved in infertility.
Full-Text [PDF 293 kb]   (765 Downloads) |   |   Full-Text (HTML)  (372 Views)  
Type of Study: Original Article |

References
1. De Sutter P. Rational diagnosis and treatment in infertility. Best Pract Res Clin Obstet Gynaecol 2006; 20: 647-664. Epub 2006/06/14. [DOI:10.1016/j.bpobgyn.2006.04.005]
2. Sharlip ID, Jarow JP, Belker AM, Lipshultz LI, Sigman M, Thomas AJ, et al. Best practice policies for male infertility. Fertil Steril 2002; 77: 873-882. Epub 2002/05/16. [DOI:10.1016/S0015-0282(02)03105-9]
3. Bonnefont-Rousselot D, Collin F. Melatonin: action as antioxidant and potential applications in human disease and aging. Toxicology 278: 55-67. Epub 2010/04/27.
4. Agarwal A, Gupta S, Sharma R. Oxidative stress and its implications in female infertility - a clinician's perspective. Reprod Biomed Online 2005; 11: 641-650. Epub 2006/01/18. [DOI:10.1016/S1472-6483(10)61174-1]
5. Tripathi A, PremKumar KV, Pandey AN, Khatun S, Mishra SK, Shrivastav TG, et al. Melatonin protects against clomiphene citrate-induced generation of hydrogen peroxide and morphological apoptotic changes in rat eggs. Eur J Pharmacol 667: 419-424. Epub 2011/06/23.
6. Ronnberg L, Kauppila A, Leppaluoto J, Martikainen H, Vakkuri O. Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 1990; 71: 492-506. [DOI:10.1210/jcem-71-2-493]
7. Bhatia AL, Manda K. Study on pre-treatment of melatonin against radiation-induced oxidative stress in mice. Environ Toxicol Pharmacol 2004; 18: 13-20. Epub 2004/09/01. [DOI:10.1016/j.etap.2004.05.005]
8. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001; 64: 43-51. Epub 2001/04/09. [DOI:10.1016/S0165-0327(00)00199-3]
9. Miller NJ, Rice-Evans C, Davies MJ, Gopinathan V, Milner A. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci (Lond) 1993; 84: 407-412. Epub 1993/04/01. [DOI:10.1042/cs0840407]
10. Agarwal A, Makker K, Sharma R. Clinical relevance of oxidative stress in male factor infertility: an update. Am J Reprod Immunol 2008; 59: 2-11. Epub 2007/12/25. [DOI:10.1111/j.1600-0897.2007.00559.x]
11. Hardeland R. Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 2005; 27: 119-130. Epub 2005/10/12. [DOI:10.1385/ENDO:27:2:119]
12. Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N, et al. Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril 2009; 92: 328-343. Epub 2008/09/23. [DOI:10.1016/j.fertnstert.2008.05.016]
13. Waldhauser F, Weiszenbacher G, Tatzer E, Gisinger B, Waldhauser M, Schemper M, et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocrinol Metab 1988; 66: 648-652. Epub 1988/03/01. [DOI:10.1210/jcem-66-3-648]
14. Wang F, Tian X, Zhang L, Tan D, Reiter RJ, Liu G. Melatonin promotes the in vitro development of pronuclear embryos and increases the efficiency of blastocyst implantation in murine. J Pineal Res 2013; 55: 267-274. Epub 2013/06/19. [DOI:10.1111/jpi.12069]
15. Brzezinski A, Seibel MM, Lynch HJ, Deng MH, Wurtman RJ. Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab 1987; 64: 865-867. Epub 1987/04/01. [DOI:10.1210/jcem-64-4-865]
16. Ishizuka B, Kuribayashi Y, Murai K, Amemiya A, Itoh MT. The effect of melatonin on in vitro fertilization and embryo development in mice. J Pineal Res 2000; 28: 48-51. Epub 2000/01/08. [DOI:10.1034/j.1600-079x.2000.280107.x]
17. Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, et al. Melatonin and pregnancy in the human. Reprod Toxicol 2008; 25: 291-303. Epub 2008/05/20. [DOI:10.1016/j.reprotox.2008.03.005]
18. Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, et al. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 2008; 44: 280-287. Epub 2008/03/15. [DOI:10.1111/j.1600-079X.2007.00524.x]
19. Lanoix D, Lacasse AA, Reiter RJ, Vaillancourt C. Melatonin: the smart killer: the human trophoblast as a model. Mol Cell Endocrinol 2012; 348: 1-11. Epub 2011/09/06. [DOI:10.1016/j.mce.2011.08.025]
20. Tan DX, Manchester LC, Terron MP, Flores LJ, Reiter RJ. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res 2007; 42: 28-42. Epub 2007/01/03. [DOI:10.1111/j.1600-079X.2006.00407.x]

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb